MeiraGTx Holdings plc (MGTX)

↓ Download CSV

CIK 0001735438 · Nasdaq · Biological Products, (No Diagnostic Substances)

  • Sector Manufacturing
  • Fiscal year ends Dec 31

In fiscal 2025, MeiraGTx Holdings plc reported revenue of $81.39M, up 144.6% from the prior year. The company ran a net loss, with a net margin of -140.3%. It held $244.43M in total assets against $250.22M in total liabilities.

Key ratios (FY2025)

-130.2%
Operating margin
-140.3%
Net margin
+144.6%
Revenue growth (YoY)
Metric (FY)2025202420232022202120202019201820172016
Revenue$81.39M$33.28M$14.02M
Operating Income-$105.97M-$164.21M-$137.06M-$116.36M-$72.76M-$62.55M-$58.27M-$78.10M-$31.68M
Net Income-$114.20M-$147.79M-$84.03M-$129.62M-$79.56M-$57.99M-$54.75M-$82.87M-$31.04M
EPS (Diluted)$-1.42$-2.12$-1.49$-2.87$-1.80$-1.54
Total Assets$244.43M$269.75M$326.74M$318.24M$320.16M$363.70M$323.89M$96.89M$25.85M
Total Liabilities$250.22M$201.92M$188.57M$200.50M$134.76M$125.14M$133.09M$15.84M$21.88M
Shareholders' Equity-$5.79M$67.83M$138.18M$117.74M$185.40M$238.56M$190.80M$81.06M-$47.37M-$17.14M
Cash & Equivalents$65.93M$103.66M$129.57M$115.52M$137.70M$209.52M$227.23M$68.08M$8.55M
Operating Cash Flow-$46.36M-$104.50M-$105.36M-$73.10M-$10.53M-$63.97M$20.04M-$58.89M-$18.06M
Capital Expenditures$3.83M$4.96M$20.17M$44.96M$46.35M$20.92M$8.98M$11.26M$10.54M
Shares Outstanding81.12M78.40M63.60M48.48M44.55M44.19M36.79M27.39M8.71M